Cargando…

Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

Interleukin (IL)-18 is a recently discovered cytokine that modulates both T helper type 1 (Th1) and Th2 responses. IL-18 is elevated during acute graft-versus-host disease (GVHD). We investigated the role of IL-18 in this disorder using a well characterized murine bone marrow transplantation (BMT) m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reddy, Pavan, Teshima, Takanori, Kukuruga, Mark, Ordemann, Rainer, Liu, Chen, Lowler, Kathy, Ferrara, James L.M.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2001
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193680/ https://www.ncbi.nlm.nih.gov/pubmed/11714750

Ejemplares similares

Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease
por: Shrestha, Pradeep, et al.
Publicado: (2023)

Long-Lasting Graft-Derived Donor T Cells Contribute to the Pathogenesis of Chronic Graft-versus-Host Disease in Mice
por: Kosugi-Kanaya, Mizuha, et al.
Publicado: (2017)

Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease
por: Matsuoka, Satomi, et al.
Publicado: (2020)

The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models
por: Teshima, Takanori, et al.
Publicado: (2021)

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
por: Murata, Makoto, et al.
Publicado: (2021)

Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus
por: Hatef, Mohammad Reza, et al.
Publicado: (2013)

Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome
Publicado: (1995)

Biomarkers in acute graft-versus-host disease: new insights
por: Srinagesh, Hrishikesh K., et al.
Publicado: (2019)

Editorial: Non-coding RNAs and Graft versus Host Disease
por: Reddy, Pavan, et al.
Publicado: (2018)

Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease
por: Kim, Stephanie, et al.
Publicado: (2020)

Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease
por: Tripathi, Gaurav, et al.
Publicado: (2022)

18β-Glycyrrhetinic acid inhibits the apoptosis of cells infected with rotavirus SA11 via the Fas/FasL pathway
por: Wang, Xiaoyan, et al.
Publicado: (2021)

Treatment with Mesenchymal Stromal Cells Overexpressing Fas-Ligand Ameliorates Acute Graft-versus-Host Disease in Mice
por: Vacaru, Andrei Mircea, et al.
Publicado: (2022)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives
por: Toubai, Tomomi, et al.
Publicado: (2016)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

Statement of Retraction: 18β-Glycyrrhetinic acid inhibits the apoptosis of cells infected with rotavirus SA11 via the Fas/FasL pathway
Publicado: (2022)

Effect of Hypertonic Saline 5% on Early Graft Function and Urinary Interleukin 18 and Neutrophil Gelatinase-Associated Lipocalin in Deceased-Donor Kidney Transplantation
por: Mojtahedzadeh, Mojtaba, et al.
Publicado: (2017)

CYTOTOXICITY IN GRAFT-VERSUS-HOST REACTION : I. ROLE OF DONOR AND HOST SPLEEN CELLS
por: Singh, Jagat N., et al.
Publicado: (1972)

The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells
por: Takashima, Shuichiro, et al.
Publicado: (2011)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Roles of Host Nonhematopoietic Cells in Autoimmunity and Donor Cell Engraftment in Graft-versus-host Disease
por: Kim, Juyang, et al.
Publicado: (2010)

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages
por: Kiener, Peter A., et al.
Publicado: (1997)

Involvement of the Fas and Fas ligand in testicular germ cell apoptosis by zearalenone in rat
por: Jee, Youngheun, et al.
Publicado: (2010)

Disruption of Fas-Fas Ligand Signaling, Apoptosis, and Innate Immunity by Bacterial Pathogens
por: Caulfield, Adam J., et al.
Publicado: (2014)

Expression Profile of Fas-Fas Ligand in Spiral Ganglion Cells During Apoptosis
por: Gu, Tae Woo, et al.
Publicado: (2014)

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Publicado: (1995)

Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease
por: Kanaya, Minoru, et al.
Publicado: (2016)

Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors
por: Parmentier, Stefani, et al.
Publicado: (2020)

Prediction of Graft-Versus-Host Disease in Humans by Donor Gene-Expression Profiling
por: Baron, Chantal, et al.
Publicado: (2007)

Sex Hormones, Apoptosis and the Fas/Fas Ligand System in Normal Endometrial Tissue Remodeling
por: Mor, Gil, et al.
Publicado: (2001)

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
por: Whangbo, Jennifer S., et al.
Publicado: (2022)

Ultrasonographic evaluation of gastrointestinal graft‐versus‐host disease after hematopoietic stem cell transplantation
por: Nishida, Mutsumi, et al.
Publicado: (2015)

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
por: Maeda, Yoshinobu, et al.
Publicado: (2019)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

Interleukin-5 Supports the Expansion of Fas Ligand-Expressing Killer B Cells that Induce Antigen-Specific Apoptosis of CD4(+) T Cells and Secrete Interleukin-10
por: Klinker, Matthew W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hql9r82n1f9q8mibvhqg71jn89